Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

NCT04542733 is registered in ClinicalTrials.gov with King Chulalongkorn Memorial Hospital as lead sponsor.

NCT NCT04542733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04542733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient
Lead sponsor
King Chulalongkorn Memorial Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 15, 2023
Completion date
July 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bk virus infection, kidney transplant infection